z-logo
open-access-imgOpen Access
Cancer Communication and User Engagement on Chinese Social Media: Content Analysis and Topic Modeling Study
Author(s) -
Liang Chen,
Pianpian Wang,
Xin Ma,
Xiaohui Wang
Publication year - 2021
Publication title -
jmir. journal of medical internet research/journal of medical internet research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.446
H-Index - 142
eISSN - 1439-4456
pISSN - 1438-8871
DOI - 10.2196/26310
Subject(s) - social media , health communication , cancer , public health , population , china , cancer prevention , psychology , medicine , world wide web , computer science , public relations , environmental health , political science , nursing , law
Background Cancer ranks among the most serious public health challenges worldwide. In China—the world’s most populous country—about one-quarter of the population consists of people with cancer. Social media has become an important platform that the Chinese public uses to express opinions. Objective We investigated cancer-related discussions on the Chinese social media platform Weibo (Sina Corporation) to identify cancer topics that generate the highest levels of user engagement. Methods We conducted topic modeling and regression analyses to analyze and visualize cancer-related messages on Weibo and to examine the relationships between different cancer topics and user engagement (ie, the number of retweets, comments, and likes). Results Our results revealed that cancer communication on Weibo has generally focused on the following six topics: social support, cancer treatment, cancer prevention, women’s cancers, smoking and skin cancer, and other topics. Discussions about social support and cancer treatment attracted the highest number of users and received the greatest numbers of retweets, comments, and likes. Conclusions Our investigation of cancer-related communication on Weibo provides valuable insights into public concerns about cancer and can help guide the development of health campaigns in social media.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here